Workflow
上海医药:尼可地尔片通过一致性评价
Zhi Tong Cai Jing·2025-09-18 07:59

Core Viewpoint - Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. received the "Drug Supplement Application Approval Notice" from the National Medical Products Administration, indicating that the drug Nicorandil tablets have passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The drug Nicorandil tablets are used for the treatment of angina pectoris [1]